MYD88 and colitis: Furthermore, by blocking the TLR4/MyD88/GSK-3β/β-catenin/ROS/NF-κB loop, MT via the MT2-mediated pathway restored MUC2 depletion, ultimately alleviating the induced colitis in mice [183].